Kymera’s degraders achieve potent and selective knockdown of IRAK4 with advantages over small molecule inhibition. IRAK4 degraders selectively cause cell death in MYD88-mutant cell lines. Small molecule kinase inhibitor is not active–demonstrating advantage of IRAK4 protein knockdown.

Join for free to read